MedPath

daptomycin

These highlights do not include all the information needed to use DAPTOMYCIN FOR INJECTION safely and effectively. See full prescribing information for DAPTOMYCIN FOR INJECTION. Initial U.S. Approval: 2003

Approved
Approval ID

6ec53f7e-9a5f-4b24-84e9-c94325750e32

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 14, 2023

Manufacturers
FDA

Hainan Poly Pharm., Co., Ltd.

DUNS: 654561638

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

daptomycin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code14335-120
Application NumberANDA215890
Product Classification
M
Marketing Category
C73584
G
Generic Name
daptomycin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateNovember 14, 2023
FDA Product Classification

INGREDIENTS (1)

DAPTOMYCINActive
Quantity: 500 mg in 20 mL
Code: NWQ5N31VKK
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

daptomycin - FDA Drug Approval Details